March 27, 2013, Hyderabad, India –Researchers at Johns Hopkins Kimmel Cancer Centre and Howard Hughes Medical Institute earlier this month published proof-of- principle data in Science Translational Medicine showing promise for detecting cancer in late –Stage Patients through DNA changes seen via noninvasive whole-genome sequencing of blood plasma.
Rabecca Leary, Ph.D., the study’s first author and a John Hopkins postdoctoral Fellow, said the blog of the New York.
Genome Centre she is hopeful the technique “Could be applied in some aspect of the clinic within the next five years or so,” since the cost of DNA sequencing continues to fall (this was the year of the much-ballyhooed $ 1000 genome).But she added that such sequencing must also be proven to detect early-Stage cancers as well, which will require large clinical trials.
No comments:
Post a Comment